KYLE HOLLYWOOD: Open Payments
NPI 1144851494 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,325 in 41 payments from 16 companies in 2025. Trend: 2023 $957 · 2024 $588 · 2025 $1,325
Food & beverage: $1,020Consulting: $305
| Company | Payments | Amount |
|---|---|---|
| Becton, Dickinson and Company | 1 | $305 |
| Amgen Inc. | 8 | $262 |
| Novartis Pharmaceuticals Corporation | 6 | $158 |
| Medtronic, Inc. | 3 | $85 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $75 |
| PFIZER INC. | 3 | $72 |
| SCPHARMACEUTICALS INC. | 3 | $59 |
| Boston Scientific Corporation | 2 | $53 |
| Abbott Laboratories | 2 | $49 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
Products named: LEQVIO, LifeVest, COREVALVE EVOLUT R, FUROSCIX, VYNDAQEL, REPATHA, CAMZYOS, JARDIANCE.
Industry payments across TX — which companies pay providers there.
